FDA NDC Directory · JSON-LD · Markdown

Potassium Phosphates

NDC 65219-658 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerFresenius Kabi USA, LLC
Marketing categoryNew Drug Application (innovator) · App NDA212832
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsDIBASIC POTASSIUM PHOSPHATE (4.72 mg/mL)
MONOBASIC POTASSIUM PHOSPHATE (4.48 mg/mL)
Marketing started20250615
Package count1

External sources

Source: openFDA. Public-domain (CC0).